Heilongjiang ZBD Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 1,003.66 million compared to CNY 726.9 million a year ago. Revenue was CNY 1,004.69 million compared to CNY 726.9 million a year ago. Net income was CNY 157.98 million compared to CNY 155.31 million a year ago. Basic earnings per share from continuing operations was CNY 0.1677 compared to CNY 0.18 a year ago. Diluted earnings per share from continuing operations was CNY 0.1677 compared to CNY 0.18 a year ago.